OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Scenarios of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022
Marc C. Shamier, Luca M. Zaeck, Hannelore M Götz, et al.
Eurosurveillance (2024) Vol. 29, Iss. 17
Open Access | Times Cited: 8
Marc C. Shamier, Luca M. Zaeck, Hannelore M Götz, et al.
Eurosurveillance (2024) Vol. 29, Iss. 17
Open Access | Times Cited: 8
Showing 8 citing articles:
Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023
Leanne P. M. van Leeuwen, Marc C. Shamier, Babs E. Verstrepen, et al.
Eurosurveillance (2024) Vol. 29, Iss. 38
Open Access | Times Cited: 3
Leanne P. M. van Leeuwen, Marc C. Shamier, Babs E. Verstrepen, et al.
Eurosurveillance (2024) Vol. 29, Iss. 38
Open Access | Times Cited: 3
Prevalence of mpox immunity among the core group and its potential to prevent future large-scale outbreaks
Lao‐Tzu Allan‐Blitz, Jeffrey D. Klausner
The Lancet Microbe (2024), pp. 100957-100957
Open Access | Times Cited: 2
Lao‐Tzu Allan‐Blitz, Jeffrey D. Klausner
The Lancet Microbe (2024), pp. 100957-100957
Open Access | Times Cited: 2
Potential determinants of the decline in mpox cases in Belgium: A behavioral, epidemiological and seroprevalence study
Elise De Vos, Liesbeth Van Gestel, Isabel Brosius, et al.
International Journal of Infectious Diseases (2024) Vol. 146, pp. 107132-107132
Closed Access | Times Cited: 1
Elise De Vos, Liesbeth Van Gestel, Isabel Brosius, et al.
International Journal of Infectious Diseases (2024) Vol. 146, pp. 107132-107132
Closed Access | Times Cited: 1
A Second Mpox Outbreak in Brazil: A Call for Action to Guarantee Equity in Access to Health Innovations
Erica Telford, Éric D’Ortenzio, Yazdan Yazdanpanah
Clinical Infectious Diseases (2024) Vol. 79, Iss. 3, pp. 660-662
Closed Access
Erica Telford, Éric D’Ortenzio, Yazdan Yazdanpanah
Clinical Infectious Diseases (2024) Vol. 79, Iss. 3, pp. 660-662
Closed Access
Orthopoxvirus-specific antibodies wane to undetectable levels one year after MVA-BN vaccination of at-risk individuals
Leanne P. M. van Leeuwen, Marc C. Shamier, Babs E. Verstrepen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Leanne P. M. van Leeuwen, Marc C. Shamier, Babs E. Verstrepen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The third generation modified vaccinia Ankara vaccine is effective in preventing the transmission of mpox
Mingwang Shen, Lei Zhang
The Lancet Regional Health - Europe (2024) Vol. 45, pp. 101052-101052
Open Access
Mingwang Shen, Lei Zhang
The Lancet Regional Health - Europe (2024) Vol. 45, pp. 101052-101052
Open Access
Mpox control strategies: using behaviour change to complement, not replace, vaccination
Marc C. Shamier, Kai J. Jonas
The Lancet Infectious Diseases (2024)
Closed Access
Marc C. Shamier, Kai J. Jonas
The Lancet Infectious Diseases (2024)
Closed Access
Will mpox disease caused by the human Mpox virus (MPXV) result in a pandemic-like situation similar to the COVID-19 pandemic
Venkataramana Kandi
Deleted Journal (2024) Vol. 21, Iss. 1
Open Access
Venkataramana Kandi
Deleted Journal (2024) Vol. 21, Iss. 1
Open Access
